Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Els Torreele

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 26, 2022
Global challenges in preparedness and response to epidemic infectious diseasesPiero Olliaro, Els Torreele
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 12, 2021
Managing the risks of making the wrong diagnosis: First, do no harmPiero Olliaro, Els Torreele
BMJ Global Health|December 4, 2024
The priority review voucher: a misconceived quid pro quoPiero Olliaro, Els Torreele
Health and Human Rights|July 1, 2021
We Cannot Win the Access to Medicines Struggle Using the Same Thinking That Causes the Chronic Access CrisisGaëlle Krikorian, Els Torreele
Bulletin of the World Health Organization|September 26, 2019
Ensuring access to life-saving medicines as countries shift from Global Fund supportMercedes Tatay, Els Torreele
Health and Human Rights|July 1, 2021
Equitable COVID-19 Vaccine AccessEls Torreele, Joseph J Amon
The Lancet. Microbe|May 24, 2021
COVID-19 vaccines: effectiveness and number needed to treat - Authors' replyPiero Olliaro, Els Torreele, Michel Vaillant
Bulletin of the World Health Organization|April 29, 2024
An mRNA technology transfer programme and economic sustainability in health careDevika Dutt, Mariana Mazzucato, Els Torreele
The Lancet. Microbe|April 26, 2021
COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the roomPiero Olliaro, Els Torreele, Michel Vaillant
Lancet (London, England)|December 19, 2025
Holding powerful corporations accountable for their health impacts: are corporate rankings effective?David McCoy, Els Torreele, Penelope Milsom
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 26, 2022
Global challenges in preparedness and response to epidemic infectious diseasesPiero Olliaro, Els Torreele
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 12, 2021
Managing the risks of making the wrong diagnosis: First, do no harmPiero Olliaro, Els Torreele
BMJ Global Health|December 4, 2024
The priority review voucher: a misconceived quid pro quoPiero Olliaro, Els Torreele
Health and Human Rights|July 1, 2021
We Cannot Win the Access to Medicines Struggle Using the Same Thinking That Causes the Chronic Access CrisisGaëlle Krikorian, Els Torreele
Bulletin of the World Health Organization|September 26, 2019
Ensuring access to life-saving medicines as countries shift from Global Fund supportMercedes Tatay, Els Torreele
Health and Human Rights|July 1, 2021
Equitable COVID-19 Vaccine AccessEls Torreele, Joseph J Amon
The Lancet. Microbe|May 24, 2021
COVID-19 vaccines: effectiveness and number needed to treat - Authors' replyPiero Olliaro, Els Torreele, Michel Vaillant
Bulletin of the World Health Organization|April 29, 2024
An mRNA technology transfer programme and economic sustainability in health careDevika Dutt, Mariana Mazzucato, Els Torreele
The Lancet. Microbe|April 26, 2021
COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the roomPiero Olliaro, Els Torreele, Michel Vaillant
Lancet (London, England)|December 19, 2025
Holding powerful corporations accountable for their health impacts: are corporate rankings effective?David McCoy, Els Torreele, Penelope Milsom
Pageof 6